Overview

Veterinary Immunodiagnostics Market is estimated to value over USD 2.4 billion by 2027 end with a CAGR of over 9.4% during the forecast period 2020 to 2027.

Increased demand for food products derived from animals, growing livestock and companion animal population, increased disposable income for expenditure on animal healthcare are some of the primary factors contributing to the growth of the market. Furthermore, increased acceptance of animals in developed countries like the United States, growing favourable policies for the usage of better diagnostic products in animals are some other factors positively affecting the veterinary immunodiagnostics market growth.

Veterinary Immunodiagnostics Market

Market Segmentation:

By Product Type
• Analyzers
• Consumables

By Animal Type
• Livestock
o Cattle
o Pigs
o Poultry
o Others
• Companion
o Feline
o Canine
o Equine
o Others

By Technology
• Enzyme-Linked Immunosorbent Assay (ELISA)
o Chemiluminescence Immunoassay
o Fluorescent Immunoassay
o Colorimetric Immunoassay
• Radioimmunoassay
• Rapid Test
• Others

By Application
• Infectious Disease
• Autoimmune Disorder
• Endocrinology& Oncology
• Bone and Mineral diseases
• Others

By End User
• Reference Laboratories
• Academic and Research Institutes
• Veterinary Hospitals & Clinics
• Point of care/ In-house testing

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

The market is fragmented into animal type, product, application, technology, end user and region. The product segment is categorised into analysers and consumables. The consumables segment is anticipated to hold the largest veterinary immunodiagnostics market share and this can be credited to a rising insistence for animal diagnostics to prevent the transfer of zoonotic diseases in humans and ensuring that the products derived from animals are of good quality. The animal type segment is fragmented into companion and livestock animals. The livestock animals is anticipated to dominate the market during the forecast period and this is due to the increased investment in the livestock animal healthcare owing to a soaring demand for products based on animals from across the world.

Regional Analysis:

The North America region is predicted to dominate the market owing to advancements in the healthcare infrastructure, increased disposable income for animal healthcare, rising companion animal population in the United States and improving reimbursement policies for animal healthcare.

Competitive Landscape:

The prominent players of the market are Abaxisinc., bioMérieux SA, IDEXX Laboratories Inc., Heska Corporation, Virbac SA, Zoetisinc., Randox Laboratories Ltd., Neogen Corporation, Woodley Equipment Company Ltd, Thermo Fisher Scientific Inc., QIAGEN N.V.

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global veterinary immunodiagnostics market by product type, by animal type, by technology, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com